1. Home
  2. MTD vs ILMN Comparison

MTD vs ILMN Comparison

Compare MTD & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mettler-Toledo International Inc.

MTD

Mettler-Toledo International Inc.

HOLD

Current Price

$1,455.31

Market Cap

28.8B

Sector

Industrials

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$142.25

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTD
ILMN
Founded
1991
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.8B
20.5B
IPO Year
1997
2000

Fundamental Metrics

Financial Performance
Metric
MTD
ILMN
Price
$1,455.31
$142.25
Analyst Decision
Buy
Hold
Analyst Count
12
16
Target Price
$1,423.33
$121.00
AVG Volume (30 Days)
120.3K
1.7M
Earning Date
02-05-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
8.22
N/A
EPS
40.11
4.46
Revenue
$3,941,791,000.00
$4,288,000,000.00
Revenue This Year
$4.30
N/A
Revenue Next Year
$4.73
$2.38
P/E Ratio
$37.31
$32.57
Revenue Growth
4.77
N/A
52 Week Low
$946.69
$68.70
52 Week High
$1,525.17
$151.34

Technical Indicators

Market Signals
Indicator
MTD
ILMN
Relative Strength Index (RSI) 51.16 55.03
Support Level $1,454.36 $140.19
Resistance Level $1,502.50 $151.00
Average True Range (ATR) 34.76 4.91
MACD 3.12 -0.25
Stochastic Oscillator 50.27 53.08

Price Performance

Historical Comparison
MTD
ILMN

About MTD Mettler-Toledo International Inc.

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: